The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Vancomycin-Resistant Enterococcus faecium Bacteremia: Risk Factors for Infection
Abstract
We describe an outbreak of vancomycin-resistant Enterococcus faecium (vanA phenotype) bacteremia on the oncology ward of a tertiary care community hospital. In 10 of the 11 cases the patients had leukemia and were neutropenic (median duration of neutropenia, 21 days) at the time of bacteremia. On average, patients received six antibiotic agents for a total of 61 agent-days prior to development of vancomycin-resistant E. faecium bacteremia. The mortality rate was 73%. Molecular typing of 22 isolates revealed that the majority (83%) represented a common strain, indicating nosocomial spread. When the 11 cases were compared to 22 matched control patients, gastrointestinal colonization with vancomycin-resistant E. faecium (odds ratio [denominator, 0] infinity, P = .005) and the use of antimicrobial agents with significant activity against anaerobes (metronidazole, clindamycin, and imipenem; odds ratio infinity, P = .02) were found to be risk factors for the development of vancomycin-resistant E. faecium bacteremia. Since no proven therapy for such infection exists, there is an urgent need to identify effective measures to prevent and control the development of vancomycin-resistant E. faecium bacteremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880 · cited 1×
“Nosocomial enterococcal bloodstream infections occur at rates of 3-4 per 10,000 discharges [3].”
BackgroundDoebbeling, B. N., Stanley, G. L., Sheetz, C. T., Pfaller, M. A., Houston, A. K., Annis, L., Li, N., & Wenzel, R. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270205 · Cited by 482
Self-citationHandwerger, S., Raucher, B., Altarac, D., Monka, J., Marchione, S., Singh, K. V., Murray, B. E., Wolff, J., & Walters, B. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.6.750 · Cited by 421
Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
Maki, D. G., & Agger, W. A. (1988) · PubMed · Cited by 328
Montecalvo, M. A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F. C., Issah, A., Cook, P., & Wormser, G. P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1363 · Cited by 318
Boyle, J. F., Soumakis, S. A., Rendo, A., Herrington, J. A., Gianarkis, D. G., Thurberg, B. E., & Painter, B. G. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.5.1280-1285.1993 · Cited by 217
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Doebbeling, B. N., Pfaller, M. A., Houston, A. K., & Wenzel, R. P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-394 · Cited by 197
Self-citationEnterococcal Bacteremia Clinical Implications and Determinants of Death
GARRISON, R. N., FRY, D. E., BERBERICH, S., & POLK, H. C. (1982) · Annals of Surgery · doi:10.1097/00000658-198207000-00010 · Cited by 166
Emergence and nosocomial transmission of ampicillin-resistant enterococci
Boyce, J. M., Opal, S. M., Potter-Bynoe, G., Laforge, R. G., Zervos, M., Furtado, G., Victor, G., & Medeiros, A. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.5.1032 · Cited by 111
Multiply-Resistant Enterococcus faecium: The Nosocomial Pathogen of the 1990s
Spera, R. V. (1992) · JAMA · doi:10.1001/jama.1992.03490180095033 · Cited by 96
Bingen, É., Denamur, É., Lambert-zechovsky, N., & Élion, J. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.9.1888-1892.1991 · Cited by 95
Wade, J. J., Desai, N., & Casewell, M. W. (1991) · Journal of Hospital Infection · doi:10.1016/0195-6701(91)90145-x · Cited by 91
'Breakthrough' Enterococcal Septicemia in Surgical Patients: 19 Cases and a Review of the Literature
Dougherty, S. H. (1983) · Archives of Surgery · doi:10.1001/archsurg.1983.01390020076013 · Cited by 77
Pallarés, R., Dick, R., Wenzel, R. P., Adams, J. R., & Nettleman, M. D. (1993) · Infection Control and Hospital Epidemiology · doi:10.1086/646765 · Cited by 74
Self-citation
Cited by
Vancomycin-Resistant Enterococci
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686 · Cited by 1,163
Practice Guidelines for the Management of Infectious Diarrhea
Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L., Tauxe, R. V., Hennessy, T., Griffin, P. M., DuPont, H., Bradley Sack, R., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318514 · Cited by 1,074
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
Huycke, M. M., Sahm, D. F., & Gilmore, M. S. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980211 · Cited by 718
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Metadata
- Authors
- Edmond, M. B., Ober, J. F., Weinbaum, D. L., Pfaller, M. A., Hwang, T., Sanford, M. D., & Wenzel, R. P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-05-01
- Volume
- 20
- Issue
- 5
- Pages
- 1126-1133
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2091288343
- Cited by
- 500
- References
- 16
- FWCI
- 24.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.